Researchers at MIT and Scripps have reported that a DNA-based virus-like particle vaccine has generated markedly higher ...

Viral mimic systems and other tech platforms could enable local testing of vaccine candidates and antiviral therapies. This ...

Researchers in George Mason University's Center for Infectious Disease Research (CIDR) and Tulane National Primate Research Center have conducted a breakthrough proof-of-concept study, published in ...

The CDC's Advisory Committee on Immunization Practices (ACIP) unanimously recommended that U.S. travelers ages 12 years and older receive the virus-like particle chikungunya vaccine (Vimkunya) when ...

Wits University says it is developing its own engineered virus-like particle systems to boost vaccine production in South Africa and beyond.

A longstanding goal of immunotherapies and vaccine research is to induce antibodies in humans that neutralize deadly viruses such as ...

A longstanding goal of immunotherapies and vaccine research is to induce antibodies in humans that neutralize deadly viruses such as HIV and ...